RxAnte
Predictive analytics solutions for healthcare organizations to manage medication adherence of high-priority patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $15.0m | Debt | |
| Total Funding | 000k | ||
Related Content
RxAnte operates in the healthcare analytics sector, focusing on improving medication adherence and reducing medical costs for health plans and providers. The company leverages predictive analytics to identify patients at risk of non-adherence and deploys targeted interventions to ensure they follow their medication regimens. RxAnte primarily serves Medicare Advantage Prescription Drug (MAPD) plans, health plans, and healthcare providers. The business model revolves around offering analytics-powered solutions and direct-to-patient interventions, which help clients achieve better clinical quality and cost savings. Revenue is generated through service contracts with health plans and providers who benefit from improved Star Ratings and reduced healthcare expenditures. The company also engages in evidence-driven discussions with pharmaceutical manufacturers to optimize drug performance and contracting.
Keywords: predictive analytics, medication adherence, healthcare costs, Medicare Part D, HEDIS quality measures, MAPD plans, health plans, clinical quality, patient interventions, Star Ratings.